CN107827762B - (2, 3-dioleoyl-propyl) trimethyl ammonium chloride and preparation method and application thereof - Google Patents

(2, 3-dioleoyl-propyl) trimethyl ammonium chloride and preparation method and application thereof Download PDF

Info

Publication number
CN107827762B
CN107827762B CN201711121867.2A CN201711121867A CN107827762B CN 107827762 B CN107827762 B CN 107827762B CN 201711121867 A CN201711121867 A CN 201711121867A CN 107827762 B CN107827762 B CN 107827762B
Authority
CN
China
Prior art keywords
dimethylamino
dioleoyl
propyl
reaction
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201711121867.2A
Other languages
Chinese (zh)
Other versions
CN107827762A (en
Inventor
吉民
刘海东
宗玺
李锐
万广朋
王冬冬
杨苏
于文渊
张影
胡海燕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southeast Pharmaceuticals Co ltd
Original Assignee
Southeast Pharmaceuticals Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southeast Pharmaceuticals Co ltd filed Critical Southeast Pharmaceuticals Co ltd
Priority to CN201711121867.2A priority Critical patent/CN107827762B/en
Publication of CN107827762A publication Critical patent/CN107827762A/en
Application granted granted Critical
Publication of CN107827762B publication Critical patent/CN107827762B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/06Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton from hydroxy amines by reactions involving the etherification or esterification of hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10Separation; Purification; Stabilisation; Use of additives

Abstract

The invention discloses a preparation method of (2, 3-dioleoyl-propyl) trimethyl ammonium chloride, which adopts the following method to prepare: firstly, 3-dimethylamino-1, 2-propanediol reacts with oleic acid or oleoyl chloride to obtain 1, 2-dioleoyl-3-dimethylamino-propane, and then reacts with methyl chloride under 0.1-10 MPa to obtain (2, 3-dioleoyl-propyl) trimethyl ammonium chloride. The method is suitable for pilot scale production, and the prepared (2, 3-dioleoyl-propyl) trimethyl ammonium chloride is a phospholipid for cationic liposome and can be used as a pharmaceutical adjuvant for various types of medicines such as injections, tablets, capsules and the like.

Description

(2, 3-dioleoyl-propyl) trimethyl ammonium chloride and preparation method and application thereof
Technical Field
The invention belongs to the field of medical auxiliary materials. In particular to (2, 3-dioleoyl-propyl) trimethyl ammonium chloride and a preparation method and application thereof.
Background
Phospholipids are important components of biological membranes, and their inherent amphiphilic properties, which are both hydrophilic and lipophilic, allow phospholipids to spontaneously form closed bilayers in aqueous media, which become the biological membrane skeleton. By utilizing the property, a novel pharmaceutical preparation technology, namely liposome, is developed. Liposomes were originally discovered by Bangham, a scholarian of the United kingdom, who used liposomes for drug carriers in 1971, when phospholipids were dispersed in water by electron microscopy. The hydrogenated soybean lecithin is prepared by taking soybean lecithin as a raw material, extracting high-purity lecithin and then carrying out catalytic hydrogenation process. The product is light yellow or milk white powder. Due to the adoption of catalysis and hydrogenation processes, unsaturated chains of unsaturated fatty acids in the molecular structure of the soybean lecithin disappear, so that the chemical stability, the dispersibility and the emulsibility of the lecithin are greatly improved. Has decolorizing and deodorizing effects, and is suitable for storage and preservation, and can be used in medicine, high-grade cosmetics, and light industry. In particular to an emulsifier and a nutrient for intravenous fat. It is used as blood fat emulsifier to prevent arteriosclerosis, and has the advantages of easy digestion, easy absorption and less residue in internal organs. The structure of (2, 3-dioleoyl-propyl) trimethylammonium chloride is shown below:
Figure GDA0002299442500000011
disclosure of Invention
The invention provides an industrial preparation method of (2, 3-dioleoyl-propyl) trimethyl ammonium chloride creatively through a large number of experiments, 3-dimethylamino-1, 2-propanediol is used as a reaction raw material and reacts with oleic acid or oleoyl chloride to obtain 1, 2-dioleoyl-3-dimethylamino-propane, then the 1, 2-dioleoyl-3-dimethylamino-propane reacts with chloromethane at a certain temperature and pressure to obtain (2, 3-dioleoyl-propyl) trimethyl ammonium chloride, and the (2, 3-dioleoyl-propyl) trimethyl ammonium chloride with the purity of more than 99 percent can be obtained through a crystallization purification method. The preparation method provided by the invention is simple to operate, simple in purification steps and suitable for industrial production.
One object of the present invention is to provide a method for preparing (2, 3-dioleoyl-propyl) trimethylammonium chloride, comprising the steps of:
(1) 3-dimethylamino-1, 2-propanediol and oleic acid are reacted under the action of a condensation reagent to obtain 1, 2-dioleoyl-3-dimethylamino-propane, or the 3-dimethylamino-1, 2-propanediol is reacted with oleoyl chloride and alkali to prepare 1, 2-dioleoyl-3-dimethylamino-propane;
Figure GDA0002299442500000021
alternatively, the first and second electrodes may be,
Figure GDA0002299442500000022
the reaction solvent of the reaction is one or more selected from tetrahydrofuran, 2-methyltetrahydrofuran, dichloromethane, trichloromethane, acetonitrile, 1, 4-dioxane, toluene, methyl tert-butyl ether, N-dimethylformamide and acetone N-methylpyrrolidone.
The condensation reagent used in the reaction is selected from DCC-DMAP system, HOBT-HATU system or N, N' -carbonyldiimidazole.
The alkali used in the reaction is selected from one or more of sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, lithium hydroxide, sodium hydroxide, potassium hydroxide, calcium hydroxide, magnesium hydroxide, barium hydroxide, sodium methoxide, sodium ethoxide, sodium tert-butoxide, potassium tert-butoxide, triethylamine, diisopropylethylamine, pyridine, N-dimethylpyridine, N-methylpiperidine, morpholine or N-methylmorpholine.
The reaction temperature of the reaction is-30 ℃ to 50 ℃, the reaction time is 1 to 10 hours, the reaction temperature is preferably-10 ℃ to 20 ℃, and the reaction time is 2 to 5 hours.
Reacting 1, 2-dioleoyl-3-dimethylamino-propane with methyl chloride to obtain (2, 3-dioleoyl-propyl) trimethyl ammonium chloride;
Figure GDA0002299442500000031
the reaction solvent of the reaction is selected from one or more of methanol, ethanol, isopropanol, water, tetrahydrofuran, 2-methyltetrahydrofuran, dichloromethane, trichloromethane, acetonitrile, 1, 4-dioxane, toluene, methyl tert-butyl ether, N-dimethylformamide and acetone N-methylpyrrolidone.
The reaction temperature of the above reaction is-20 ℃ to 200 ℃. The reaction pressure of the above reaction is 0.1 to 10 MPa. The reaction pressure is preferably 1.5MPa, the temperature is 60-90 ℃, and the reaction is carried out for 5-24 h.
At normal temperature and normal pressure, the methyl chloride is in a gas state, the methyl chloride can react with the 1, 2-dioleoyl-3-dimethylamino-propane in a liquid state by selectively controlling the pressure and the temperature, for example, the temperature is-30 ℃ to-25 ℃, the methyl chloride is in a liquid state, the normal pressure is selected, and when the temperature is higher than-23.7 ℃, the gaseous methyl chloride is converted into the liquid state to participate in the reaction by adjusting the pressure in the reaction kettle.
The preparation method of the invention can further comprise a purification step of performing crystallization purification on the (2, 3-dioleoyl-propyl) trimethyl ammonium chloride by using one or more of methanol, ethanol, isopropanol, water, tetrahydrofuran, 2-methyltetrahydrofuran, dichloromethane, trichloromethane, acetonitrile, 1, 4-dioxane, toluene, methyl tert-butyl ether, N-dimethylformamide, acetone and N-methylpyrrolidone.
Another object of the present invention is to provide a hydrogenated soybean lecithin, which is characterized by being prepared and purified by the method of the present invention, wherein the purity of (2, 3-dioleoyl-propyl) trimethyl ammonium chloride is not less than 99%.
The invention also aims to provide the application of the hydrogenated soybean lecithin as a medical auxiliary material for preparing medicines or health-care products.
The product obtained by the invention has stable quality, and meets the standards of medical injection and pharmaceutical excipients after degerming and vacuum drying.
Drawings
FIG. 1 is a HPLC chart of (2, 3-dioleoyl-propyl) trimethylammonium chloride prepared by the method of the present invention measured by external standard method.
Detailed Description
The following examples will aid the understanding of the present invention but should not be construed as limiting the invention.
Example 11 preparation of 2, 2-dioleoyl-3-dimethylamino-propane
The method comprises the following steps: adding 500g of 3-dimethylamino-1, 2-propanediol, 1600g of diisopropylethylamine and 15L of tetrahydrofuran into a reaction kettle, cooling to minus 5 ℃, replacing the gas in the kettle with nitrogen, slowly dropwise adding 2800g of tetrahydrofuran solution of oleoyl chloride, keeping the temperature in the reaction kettle not higher than 10 ℃, then slowly heating to room temperature, continuing to react for 2-3 hours, concentrating under reduced pressure, adding ethyl acetate and cold water, separating, washing an organic phase with saturated saline solution, separating, drying the organic phase with anhydrous magnesium sulfate, and filtering. The organic phase was concentrated and dried under reduced pressure to obtain 2580g of 1, 2-dioleoyl-3-dimethylamino-propane in a yield of 95%.
The method 2 comprises the following steps: adding oleic acid (751g, 251mmol, 3.0 equiv.), DCC (3.0 equiv.), DMAP (2.1 equiv.) and 1L chloroform into a reaction bottle, cooling to 5-10 ℃, replacing the gas in the reaction bottle with nitrogen, slowly dropping a chloroform solution of 3-dimethylamino-1, 2-propanediol (100g, 84mmol), keeping the temperature in the reaction kettle not higher than 10 ℃, then slowly raising the temperature to room temperature, continuing to react for 12-20 hours, concentrating under reduced pressure, purifying the crude product by silica gel chromatography to obtain 468g of 1, 2-dioleoyl-3-dimethylamino-propane, wherein the yield is 86%.
1H NMR(300MHz,d6DMSO)=5.53(m,4H),4.57(m,1H),2.11-2.76(m,14H),2.83(s,6H),1.21-1.36(m,40H),0.89(m,6H);MS(m/z)[M+H]+calcd for C41H78NO4+648.6,found 648.5。
EXAMPLE 2 preparation of (2, 3-dioleoyl-propyl) trimethylammonium chloride
The influence of the reaction temperature, pressure and solvent on the product was examined with reference to Table 1. Adding 1, 2-dioleoyl-3-dimethylamino-propane and a reaction solvent into a high-pressure reaction kettle, replacing gas in the kettle with nitrogen, then replacing the nitrogen with methyl chloride, slowly increasing the pressure to 1.5MPa, keeping the pressure, slowly increasing the temperature to a set temperature, reacting at the temperature and the pressure for 5-24 hours, cooling to room temperature, emptying the pressure, transferring the reaction liquid into a normal-pressure reaction kettle, slowly adding a crystallization solvent, separating out white solid, continuously stirring at the room temperature for 2-5 hours, filtering, washing the solid with the crystallization solvent, drying the solid under reduced pressure to obtain (2, 3-dioleoyl-propyl) trimethyl ammonium chloride, and calculating the conversion rate of the raw materials.
TABLE 1 Effect of different temperatures and pressures on feedstock conversion
1, 2-dioleoyl-3-dimethylamino-propane Reaction solvent Temperature of Pressure of Conversion rate
1 50g Tetrahydrofuran (THF) 50 1.5MPa 26.3%
2 50g Tetrahydrofuran (THF) 60 1.5MPa 53.5%
3 50g Tetrahydrofuran (THF) 70 1.5MPa 87.2%
4 50g Tetrahydrofuran (THF) 85 1.5MPa 95.3%
5 50g Tetrahydrofuran (THF) 90 1.5MPa 95.2%
The results show that the conversion of the starting material is highest at a pressure of 1.5MPa as the reaction temperature is increased to 85 ℃. The reaction conditions are selected for preparation. The influence of the reaction solvent and the purification solvent on the yield and purity of the product was examined with reference to the conditions of Table 3.
HPLC conditions:
using a C18 column, e.g. Phenomenex, Gemini, 5u C18110A: taking methanol-acetate buffer (pH 4.5) ═ 9:1 as mobile phase A, and chloroform-methanol-acetate buffer (pH 4.5) ═ 30:20:1 as mobile phase B; the column temperature is 40 ℃; gradient elution was performed as in table 2; an evaporative light scattering detector Agilent A380 at 40 ℃ under a nitrogen flow rate of 1.5L per minute.
TABLE 2
Time (minutes) Mobile phase A (%) Mobile phase B (%)
0 85 15
30 0 100
30.1 85 15
40 85 15
TABLE 3 Effect of different reaction and purification solvents on product yield and purity
DOTAP Reaction solvent Crystallization solvent Yield% Purity of
1 10.0g Tetrahydrofuran (THF) Methyl tert-butyl ether 89% 99%
2 10.0g Tetrahydrofuran (THF) Acetone (II) 91% 96.5%
3 10.0g Chloroform Methyl tert-butyl ether 73% 99%
4 10.0g Methylene dichloride Methyl tert-butyl ether 87% 98.3%
5 10.0g Chloroform Acetone (II) 83% 97.9%
6 10.0g Methylene dichloride Acetone (II) 92% 97.3%
The results show that the use of methyl tert-butyl ether as crystallization solvent enables a better product purity to be achieved. This condition was chosen to produce (2, 3-dioleoyl-propyl) trimethylammonium chloride.
Adding 2200g of 1, 2-dioleoyl-3-dimethylamino-propane and 13.2L of tetrahydrofuran into a high-pressure reaction kettle, replacing gas in the kettle with nitrogen, then replacing the nitrogen with methyl chloride, slowly increasing the pressure to 1.5MPa, keeping the pressure, slowly increasing the temperature to 85 ℃, reacting at the temperature and the pressure for 5-24 hours, cooling to room temperature, emptying the pressure, transferring the reaction liquid into a normal-pressure reaction kettle, slowly adding 10L of methyl tert-butyl ether, separating out white solid, continuously stirring at the room temperature for 2-5 hours, filtering, washing the solid with methyl tert-butyl ether, and drying the solid under reduced pressure to obtain 2107g of (2, 3-dioleoyl-propyl) trimethyl ammonium chloride, wherein the yield is 89%, and the HPLC purity of the product is 99.1% by adopting an external standard method, and the results are shown in figure 1.
1H NMR(300MHz,d6DMSO)=5.62(m,4H),4.63(m,1H),2.14-2.72(m,14H),3.62(s,9H),1.19-1.32(m,40H),0.91(m,6H);MS(m/z)[M+H]+calcd for C41H78NO4+648.6,found 648.5。white solid。

Claims (5)

  1. A method for preparing (2, 3-dioleoyloxy-propyl) trimethylammonium chloride, comprising the steps of:
    (1) 3-dimethylamino-1, 2-propanediol and oleic acid are reacted under the action of a condensation reagent to obtain 1, 2-dioleoyloxy-3-dimethylamino-propane, or the 3-dimethylamino-1, 2-propanediol is reacted with oleoyl chloride and alkali to prepare 1, 2-dioleoyloxy-3-dimethylamino-propane,
    Figure 960151DEST_PATH_IMAGE002
    alternatively, the first and second electrodes may be,
    Figure 361791DEST_PATH_IMAGE004
    (2) reacting 1, 2-dioleoyloxy-3-dimethylamino-propane with chloromethane to obtain (2, 3-dioleoyloxy-propyl) trimethyl ammonium chloride, wherein the reaction solvent is tetrahydrofuran, the reaction temperature is 60-90 ℃, the reaction pressure is 1.5MPa, the reaction time is 5-24h,
    Figure 632366DEST_PATH_IMAGE006
    (3) and (3) crystallizing and purifying the product of the step (2) by using methyl tert-butyl ether.
  2. 2. The method according to claim 1, wherein the reaction solvent in step (1) is one or more selected from tetrahydrofuran, 2-methyltetrahydrofuran, dichloromethane, chloroform, acetonitrile, 1, 4-dioxane, toluene, methyl tert-butyl ether, N-dimethylformamide, acetone, and N-methylpyrrolidone.
  3. 3. The process according to claim 1, wherein the condensation reagent used in step (1) is selected from the group consisting of DCC-DMAP system, HOBT-HATU system and N, N' -carbonyldiimidazole.
  4. 4. The method according to claim 1, wherein the base used in step (1) is one or more selected from the group consisting of sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, lithium hydroxide, sodium hydroxide, potassium hydroxide, calcium hydroxide, magnesium hydroxide, barium hydroxide, sodium methoxide, sodium ethoxide, sodium tert-butoxide, potassium tert-butoxide, triethylamine, diisopropylethylamine, pyridine, N-lutidine, N-methylpiperidine, morpholine and N-methylmorpholine.
  5. 5. The method according to claim 1, wherein the reaction temperature in the step (1) is from-30 ℃ to 80 ℃.
CN201711121867.2A 2017-11-14 2017-11-14 (2, 3-dioleoyl-propyl) trimethyl ammonium chloride and preparation method and application thereof Active CN107827762B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711121867.2A CN107827762B (en) 2017-11-14 2017-11-14 (2, 3-dioleoyl-propyl) trimethyl ammonium chloride and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711121867.2A CN107827762B (en) 2017-11-14 2017-11-14 (2, 3-dioleoyl-propyl) trimethyl ammonium chloride and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN107827762A CN107827762A (en) 2018-03-23
CN107827762B true CN107827762B (en) 2020-10-02

Family

ID=61654372

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711121867.2A Active CN107827762B (en) 2017-11-14 2017-11-14 (2, 3-dioleoyl-propyl) trimethyl ammonium chloride and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN107827762B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103547560A (en) * 2011-05-20 2014-01-29 默克专利股份有限公司 Stable crystal modifications of DOTAP chloride

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264618A (en) * 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
WO2012024233A2 (en) * 2010-08-14 2012-02-23 The Regents Of The University Of California Zwitterionic lipids
DK3231790T3 (en) * 2014-12-08 2020-01-27 Nof Corp PROCEDURE FOR PREPARING CATIONIC LIPID
CN104922141B (en) * 2015-05-28 2016-05-25 厦门成坤生物技术有限公司 A kind of siRNA composition that is used for the treatment of virus B hepatitis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103547560A (en) * 2011-05-20 2014-01-29 默克专利股份有限公司 Stable crystal modifications of DOTAP chloride

Also Published As

Publication number Publication date
CN107827762A (en) 2018-03-23

Similar Documents

Publication Publication Date Title
CN109311838A (en) The biosynthesis of cannboid prodrug
WO2016004704A1 (en) Gastrodin production process
CN103374050B (en) One prepares 5,6, the method for 4 '-trihydroxyflavone-7-0-D-glucuronic acid
CN107827762B (en) (2, 3-dioleoyl-propyl) trimethyl ammonium chloride and preparation method and application thereof
US20150133652A1 (en) Acetatic abiraterone trifluoroacetate and preparation method and application of same
CN111471080B (en) ocotillol type ginsengenin A-ring amino thiazole ring derivative and preparation method thereof
CN113582880A (en) Preparation method of (3-aminobicyclo [1.1.1] pentane-1-yl) carbamic acid tert-butyl ester
CN103374049B (en) One prepares 5,6, the method for 4 '-trihydroxyflavone-7-0-D-glucuronic acid
CN112745309B (en) Chromone 3-position nitric oxide donor derivative and preparation method and application thereof
CN101215281A (en) Isoflavone sulfonate derivatives and synthetic method thereof
CN105523957B (en) The method that one kettle way prepares scheme for lacosamide
CN113549054B (en) Vonoprazan fumarate intermediate and preparation method thereof
EP3154942B1 (en) Preparation of piperidine-4-carbothioamide
CN109678919B (en) Preparation method of methylprednisolone succinate impurity
CN108101892B (en) Chrysin non-natural amino acid derivative and preparation method and application thereof
CN102731437A (en) Preparation method of 4-piperazine-3-trifluoromethylaniline hydrochloride
CN107513046B (en) Synthesis method of Coxstat
CN106167465B (en) A kind of Edaravone dimer impurity compound and preparation method thereof
CN114181270B (en) Canagliflozin impurity, preparation method and removal method
CN112745310B (en) Chromone 2-piperazine linked furazan derivative and preparation method and application thereof
CN109704925B (en) Germacrone derivative and preparation method and application thereof
CN115594690B (en) Metformin biotin MetBio, synthesis method thereof and application thereof in nucleic acid drug delivery
CN107325030A (en) The new trans-stilbene class antitumor agent of one class
CN112094241B (en) Preparation method of 1, 4-diazaspiro [5,5] undecane-3-ketone
CN109400666B (en) Preparation method of diosgenin ether

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CB03 Change of inventor or designer information
CB03 Change of inventor or designer information

Inventor after: Zong Xi

Inventor after: Yu Wenyuan

Inventor after: Wang Dongdong

Inventor after: Hu Haiyan

Inventor after: Ji Min

Inventor after: Zhang Ying

Inventor before: Ji Min

Inventor before: Hu Haiyan

Inventor before: Liu Haidong

Inventor before: Zong Xi

Inventor before: Li Rui

Inventor before: Wan Guangpeng

Inventor before: Wang Dongdong

Inventor before: Yang Su

Inventor before: Yu Wenyuan

Inventor before: Zhang Ying